/PRNewswire/ The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around.
SAN DIEGO, CA / ACCESSWIRE / May 17, 2022 / International Stem Cell Corporation (OTC PINK:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology
International Stem Cell Co. (OTCMKTS:ISCO – Get Rating) shares passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.48 and traded as high as $0.51. International Stem Cell shares last traded at $0.49, with a volume of 61,133 shares changing hands. The company has a […]
SAN DIEGO, CA / March 30, 2022 / International Stem Cell Corporation , a California-based clinical stage biotechnology company developing novel stem cell-based therapies and. | March 30, 2022
SAN DIEGO, CA / ACCESSWIRE / March 30, 2022 / International Stem Cell Corporation (OTCQX:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage biotechnology